AI assistant
FirstFarms — Interim / Quarterly Report 2025
Aug 27, 2025
3433_rns_2025-08-27_3c8027c2-7279-441f-add0-c91fa38ced9d.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
{0}------------------------------------------------
INTERIM FINANCIAL REPORT FOR 1 JANUARY - 30 JUNE 2025 FOR FIRSTFARMS A/S


{1}------------------------------------------------
CONTENT
| Half year result affected by foot and mouth disease and higher prices on cattle . 3 |
|---|
| Financial highlights and key ratios . 6 |
| Expectations . 7 |
| Management statement . 8 |
| Income statement and total income statement . 10 |
| Balance sheet . 11 |
| Equity statement . 13 |
| Cash flow statement . 14 |
| Segment information . 15 |
| Turnover . 16 |
| Investor information . 17 |
This report is composed in Danish and English. In case of doubt, in relation to interpretation, the Danish version takes precedence.
{2}------------------------------------------------
HALF YEAR RESULT AFFECTED BY FOOT AND MOUTH DISEASE AND HIGHER PRICES ON CATTLE
FirstFarms A/S delivered a result before tax of 7 mDKK in the first half year of 2025.
Good growing conditions in the field and higher cattle prices partially offset the negative consequences of an outbreak of foot and mouth disease (FMD) in the milk production and prices below budget in the pig and crop production.
Key figures in the first half year 2025
FirstFarms has in the accounting period realised:
- A turnover of 192 mDKK (2024: 220 mDKK)
- An EBITDA of 54 mDKK (2024: 65 mDKK)
- An EBIT of 22 mDKK (2024: 35 mDKK)
- A result before tax of 7 mDKK (2024: 18 mDKK)
The turnover deceased with 28 mDKK, whereas EBITDA decreased with 11 mDKK and EBIT with 13 mDKK. Result before tax was 12 mDKK less that compared to the same period the year before.
The decrease in the key figures is primarily due to loss related to the outbreak of FMD on the Group's farm in Plavecky Stvrtok, Slovakia in the spring. FMD will affect the operation for the rest of 2025 and in 2026.
The half year result is also affected by the prices in
the pig production, which did not live up to the budgeted along with a smaller effect from the value adjustments on the pigs.
The value adjustment of the biological assets was reduced by 1 mDKK in first half year 2025 compared to first half year 2024.
The total positive impact on the value adjustment of pigs, cattle and crops, which are not harvested, is 42 mDKK, whereas value adjustment of culling of the milking cows, due to FMD, is negative with 35 mDKK. In addition, 31 mDKK has been included in insurance sum, which is recognised under other operating income, so that the net impact of culling of the animals in connection with FMD is 4 mDKK.
Construction work
Two out of three major construction projects continued as planned in first half year.
Expansion of the area under irrigation in Romania was completed in June. The expansion is on 700 hectares. The total area under irrigation in Romania is now 2,000 hectares.
Also in Romania, the double up on silo capacity to 46,000 tons is close to be finished. The facility is expected ready for inauguration in September 2025.
Construction of the dairy in connection with the milk production in Plavecky Stvrtok is temporarily on hold, as a consequence of the outbreak of FMD on the farm. The construction is expected to be resumed in second half year 2025.
Pigs
The turnover in piglets and slaughter pigs is in first half year 2025 decreased compared to same period last year. In first half year 2025, the sales price of piglets was 606 DKK/pcs. against 736 DKK/pcs. in first half year 2024, and for slaughter pigs 13.90 DKK/kg against 15.64 DKK/kg.
The decreasing sales prices were expected, and the prices are still reasonable. FirstFarms expects prices at present level for the rest of the year.
FirstFarms' pig production in Gabčíkovo, Slovakia, was in first half year challenged by several outbreaks of foot and mouth disease in the vicinity.
Sales were for a period made complicated due to transport restrictions, as a result of FMD, and production thus difficult.
Crops
Crop prices have been reasonable in first half year, but the trend has been downward.

{3}------------------------------------------------

The turnover from sale of crops is 24 mDKK higher in first half year 2025 compared to first half year 2024. This is primarily due to crops from 2024 in stock were bigger and have been sold during first half year 2025.
A slight increase in prices is expected in second half year.
Volumes, price and quality are strongly linked to the weather. The growing season has been without major challenges, and FirstFarms' crops are generally doing well. The harvest is well underway, and a good yield and generally good quality is expected.
FirstFarms sells net approx. 60 percent of the crop production. The remaining 40 percent is used for feed.
Land
FirstFarms considers agricultural land as an inflation proof real asset, and the company's agricultural land makes up a quarter of the balance sheet.
Milk
FirstFarms' milk production has been significantly affected by the outbreak of FMD in Slovakia. The primary focus in Q2 has been on re-establishing the production.
In June 2025, FirstFarms was given permission to start
up milk production at another of the company's cattle farms in Slovakia. Approx. 300,000 kg om milk is produced in the month of June. Mid-August, 17,000 kg milk is produced per day compared to 95,000 kg before outbreak of FMD.
FMD has affected the first half year result negative with 20 mDKK - including operating loss.
Status on FMD
Since the authorities on 30 March 2025 confirmed, that FirstFarms had an outbreak of FMD on the cattle farm in Plavecky Stvrtok and 3,521 animals on the farm had to be culled, a complex cleaning, preparation, planning and logistic work has been going on.
It has gone, and continues to go, well.
Cleaning, washing and disinfection on the farm has been completed by FirstFarms, and the Slovak authorities have carried out two mandatory final disinfections in August. FirstFarms is thus ready to put in 40 test cows at the farm. The cows are moved throughout the farm for a period of three weeks, after which they are tested for FMD. If the animals are free of the disease, the authorities release the farm.
FirstFarms expects to put in the first milking cows and resume the milk production in Plavecky Stvrtok during Q4-2025.
The work of finding a new herd is so progressed, that FirstFarms expects to have re-establised the full herd on the farm already in 2026.
Previously, the Group expected that it would take two years before the herd was fully re-established.
The management highlights the extraordinary efforts of the employees, good cooperation with the Slovak authorities, and the great goodwill of colleagues in the industry as the reason why the work of preparing for a new herd has gone well, and that a full re-establishment of the herd can be done relatively quickly.
Expectations to 2025
As a direct consequence of the FMD outbreak, the Group adjusted downwards the expectations for the year's result by 45 mDKK on 31 March 2025.
In July 2025, the Group was given the opportunity to apply for regional subsidies for investments in animals and to cover other costs related to the outbreak.
{4}------------------------------------------------

FirstFarms expects a subsidy of 40-55 mDKK, of which 10 mDKK will have an impact on the result in 2025. Therefore, the Group adjusted upwards its expectations for the year's result on 11 July.
FirstFarms expects in 2025:
- An EBITDA of 85-125 mDKK
- An EBIT of 15-55 mDKK
FirstFarms' primary focus area in 2025 is to fully re-establish the milk production, as quickly and safely as possible. The focus is also on continuously operating the rest of the production more efficiently, productively, circularly and sustainably.
The Group continues with sustainability initiatives regarding reducing emissions. Work is being done on a double materiality analysis, and the Group is relating to the adopted Omnibus proposal, including focusing on relevant sustainability initiatives in FirstFarms.
The rest of 2025 will focus, among other things, on developing sustainability plans for all FirstFarms' farms. The sustainability agenda is an integrated part of everyday life in the Group.
Financial items
Net financial items are a cost of 16 mDKK against net 17 mDKK in 2024. The development in financial items is influenced by the fact that in 2024 there was a net income from hedging crops of 3 mDKK. In 2025, the interest level has decreased.
Equity
During the period, equity increased by 95 mDKK to 916 mDKK, primarily due to conversion of bond on 6 March 2025.
The balance sheet
The balance sheet total for the Group per 30 June 2025 amounts to 1,732 mDKK, which is on par with the same period last year and an increase of 47 mDKK compared to compared to 31 December 2024.
The main reason is seasonal fluctuations in inventory, biological assets and investments in fixed assets.
Cash flows
Cash flows from operations amount to 2 mDKK against 18 mDKK in 2024. The cash flows in 2025 were influenced by lack of sale of milk for the Slovak cattle herd. Cash flows from investment activity amount to 86 mDKK. The primary investment relates to irrigation in Romania and dairy in Slovakia.
Events after the balance sheet date
No events have occurred after the balance sheet date that are significant for the group's position as of 30 June 2025.
Risk assessment
FirstFarms has in the annual report of 2024 described the most essential risks for the company, and it is the management's opinion that this description is still adequate.
The annual report and the risk assessment can be found on the company's website: www.firstfarms.com.
Accounting policies
The interim financial report is prepared in accordance with IAS 34 "Presentation of interim financial reports" as adopted by the EU and Danish disclosure requirements for listed companies.
Accounting policies are unchanged compared to the consolidated financial statement and annual report for 2024, to which is referred.
{5}------------------------------------------------
FINANCIAL HIGHLIGHTS AND KEY RATIOS
| FINANCIAL HIGHLIGHTS | Group | Group | Group | Group | Group | |
|---|---|---|---|---|---|---|
| tDKK | H1 2025 | H1 2024 | Q2 2025 | Q2 2024 | 2024 | |
| Net turnover | 192,2 | 219,7 | 89,8 | 115,8 | 454,0 | |
| Gross profit/loss | 112,4 | 119,0 | 74,7 | 58,4 | 217,4 | |
| Result before depreciations (EBITDA) | 54,4 | 65,0 | 42,6 | 28,7 | 105,3 | |
| Profit/loss from primary operations (EBIT) | 22,1 | 35,3 | 26,5 | 13,1 | 43,0 | |
| Net financial items | -15,6 | -17,3 | -5,6 | -8,5 | -34,1 | |
| Profit before tax | 6,5 | 18,0 | 20,8 | 4,6 | 8,9 | |
| Net profit | 4,8 | 14,0 | 17,5 | 3,7 | 16,3 | |
| Non-current assets | 1297,8 | 1242,1 | 1297,8 | 1242,1 | 1271,4 | |
| Current assets | 434,2 | 491,8 | 434,2 | 491,8 | 413,5 | |
| Total assets | 1732,0 | 1733,9 | 1732,0 | 1733,9 | 1684,9 | |
| Share capital | 122,5 | 111,5 | 122,5 | 111,5 | 111,5 | |
| Equity | 915,6 | 820,5 | 915,6 | 820,5 | 819,2 | |
| Non-current liablities | 623,1 | 725,5 | 623,1 | 725,5 | 718,8 | |
| Current liabilities | 193,3 | 187,3 | 193,3 | 187,3 | 146,9 | |
| Net interest bearing debt | 551,9 | 438,9 | 551,9 | 438,9 | 551,0 | |
| Cash flow from primary operations | 12,9 | 42,0 | -22,9 | 30,5 | 88,7 | |
| Cash flow from operating activities | 1,6 | 17,5 | -22,3 | 25,0 | 47,1 | |
| Cash flow from investment activities, net | -86,2 | -55,2 | -58,0 | -48,3 | -89,4 | |
| Of which for investment in tangible assets | -86,4 | -60,3 | -58,3 | -51,4 | -114,3 | |
| Cash flow from financing activities | 18,6 | 193,0 | -162,5 | 45,5 | 154,1 | |
| Total cash flow | -66,0 | 3,9 | -242,8 | 22,2 | 111,8 | |
| KEY RATIOS | ||||||
| Gross margin | 58.5 | 54.2 | 83.1 | 50.4 | 47.9 | |
| EBITDA margin | 28.3 | 29.6 | 47.5 | 24.7 | 23.2 | |
| Operating margin | 11.5 | 16.1 | 29.5 | 11.3 | 9.5 | |
| Solvency ratio | 52.9 | 47.3 | 52.9 | 47.3 | 48.6 | |
| Earnings per share, DKK | 0.4 | 1.3 | 1.4 | 0.3 | 1.6 | |
| Diluted earnings per share, DKK | 0.4 | 1.2 | 1.4 | 0.3 | 1.6 | |
| NIBD/EBITDA | 5.1 | 4.1 | 4.3 | 4.0 | 5.2 | |
| Return on shareholders' equity | 1.1 | 3.6 | 8.1 | 1.9 | 2.2 | |
| Average number of employees | 383 | 385 | 379 | 386 | 389 |

{6}------------------------------------------------

EXPECTATIONS
FirstFarms maintains the latest announced expectations for the year of an EBITDA in the level of 85-125 mDKK and an EBIT of 15-55 mDKK.
| Announced expectations 2024 (mDKK) | EBITDA | EBIT |
|---|---|---|
| 11 July 2025 (company announcement no. 26 | 85-125 | 15-55 |
| 31 March 2025 (company announcement no. 17) | 70-110 | 0-40 |
| 13 March 2025 (company announcement no. 11) | 115-155 | 45-85 |
{7}------------------------------------------------
MANAGEMENT STATEMENT
The Board of directors and the management of i FirstFarms A/S have today discussed and approved the interim financial report for the period 1 January – 30 June 2025.
Billund, 27 August 2025
The interim financial accounts, which has not been audited or reviewed by the independent auditors of the Company, has been prepared in accordance with IAS 34 – "Interim Financial Reporting" as adopted by the EU and additional Danish disclosure requirements for interim reports of listed companies.
In our opinion the interim financial accounts give a true and fair view of the Group's assets, liabilities and financial position at 30 June 2025 and of the results of the Group's operations and cash flows for the period 1 January – 30 June 2025.
Further, in our opinion the Management's review gives a true and fair overview of the development in the Group's operations and financial matters, the results of the Group's operations and the Group's financial position as a whole.
| Management | ||
|---|---|---|
| Michael Hyldgaard Co-CEO |
Søren Bredvig Co-CEO |
|
| Board of directors | ||
| Asbjørn Børsting Chairman |
Henrik Hougaard Vice Chairman |
|
| Bendt Wedell | Claus Ewers | |
| Lise Kaae | Jesper Pagh |

{8}------------------------------------------------

{9}------------------------------------------------
INCOME STATEMENT AND TOTAL INCOME STATEMENT
| INCOME STATEMENT tDKK |
Group H1 2025 |
Group H1 2024 |
Group Q2 2025 |
Group Q2 2024 |
Group 2024 |
|---|---|---|---|---|---|
| Net turnover | 192,161 | 219,698 | 89,820 | 115,849 | 454,019 |
| Public subsidies | 28,017 | 37,614 | 13,967 | 23,164 | 71,894 |
| Other operating income | 35,345 | 2,823 | 34,560 | 1.388 | 6,796 |
| Value adjustment of biological assets | 7,161 | 8,445 | 6,476 | -2,680 | -21,085 |
| Total income | 262,684 | 268,580 | 144,823 | 137,721 | 511,624 |
| Cost of sales | -106,921 | -111,358 | -48,471 | -57,549 | -211,383 |
| Other external costs | -43,325 | -38,176 | -21,679 | -21,790 | -82,853 |
| Gross profit/loss | 112,438 | 119,046 | 74,673 | 58,382 | 217,388 |
| Staff costs | -58,054 | -54,032 | -32,042 | -29,726 | -112,072 |
| EBITDA | 54,384 | 65,014 | 42,631 | 28,656 | 105,316 |
| Depreciations | -32,293 | -29,703 | -16,172 | -15,515 | -62,366 |
| EBIT | 22,091 | 35,311 | 26,459 | 13,141 | 42,950 |
| Financial income | 2,602 | 5,286 | 1,844 | 2,814 | 10,282 |
| Financial costs | -18,178 | -22,581 | -7,477 | -11,344 | -44,375 |
| Pre-tax result | 6,515 | 18,016 | 20,826 | 4,611 | 8,857 |
| Tax on net profit | -1,759 | -3,982 | -3,335 | -894 | 7,492 |
| Net profit | 4,756 | 14,034 | 17,491 | 3,717 | 16,349 |
| Earnings per share | 0.39 | 1.26 | 1.43 | 0.33 | 1.55 |
| Diluted earnings per share | 0.39 | 1.24 | 1.43 | 0.33 | 1.55 |
| TOTAL INCOME STATEMENT | Group | Group | Group | Group | Group |
| tDKK | H1 2025 | H1 2024 | Q2 2025 | Q2 2024 | 2024 |
| Net profit | 4,756 | 14,034 | 17,491 | 3,717 | 16,349 |
| Other total income | |||||
| Items that can be reclassified to teh income statement: | |||||
| - Result minority interests | 33 | -487 | 45 | -487 | -60 |
| - Exchange rate adjustments by conversion of foreign units | -758 | -4,247 | -4.166 | 650 | -14.385 |
| Hedging instruments | |||||
| - Value adjustment for the period | 0 | 0 | 0 | 0 | 0 |
| - Value adjustment of reclassified to financial items | 0 | 0 | 0 | 0 | 0 |
| - Tax of other total income | 0 | 0 | 0 | 0 | 0 |
| Other total income after tax | -725 | -4,734 | -4.121 | 163 | -14,445 |
| Total income | 4,031 | 9,300 | 13,370 | 3,880 | 1,904 |

{10}------------------------------------------------
BALANCE SHEET
| BALANCE SHEET ASSETS tDKK |
Group H1 2025 |
Group H1 2024 |
Group 2024 |
|---|---|---|---|
| ASSETS | |||
| Non-current assets | |||
| Intangible assets | |||
| Goodwill | 16,083 | 16,083 | 16,083 |
| Total intangible assets | 16,083 | 16,083 | 16,083 |
| Tangible assets | |||
| Land | 439,148 | 425,571 | 440,901 |
| Land lease contracts (IFRS 16) | 54,140 | 51,540 | 58,757 |
| Buildings | 406,826 | 414,434 | 400,095 |
| Plant and machinery | 181,645 | 180,630 | 177,393 |
| Fixtures and fittings, tools and equipment | 12,633 | 14,552 | 13,339 |
| Assets under construction and prepayment | 88,673 | 30,945 | 39,887 |
| Total tangible assets | 1183,065 | 1.117,672 | 1.130,372 |
| Biological assets | |||
| Basic herd | 33,964 | 59,373 | 60,239 |
| Total biological assets | 33,964 | 59,373 | 60,239 |
| Other non-current assets | |||
| Other capital shares | 45,063 | 45,063 | 45,063 |
| Other receivables Deferred tax assets |
0 19,671 |
0 3,892 |
0 19,597 |
| Total other non-current assets | 64,734 | 48,955 | 64,660 |
| Total non-current assets | 1.297,846 | 1.242,083 | 1.271,354 |
| Current assets | |||
| Inventories | 61,600 | 61,124 | 118,344 |
| Biological assets – breeding and crops | 217,700 | 163,835 | 100,760 |
| Receiveables from sale | 25,154 | 38,627 | 28,538 |
| Other receivables | 47,911 | 37,452 | 16,447 |
| Receivable corporation tax | 4,431 | 4,429 | 1,207 |
| Accruals and deferred expenses | 5,660 | 5,185 | 10,545 |
| Cast at bank and in hand | 71,732 | 181,174 | 137,703 |
| Total current assets | 434,188 | 491,826 | 413,544 |
| TOTAL ASSETS | 1.732,034 | 1.733,909 | 1.684,898 |

{11}------------------------------------------------
| BALANCE SHEET EQUITY AND LIABILITIES tDKK |
Group H1 2025 |
Group H1 2024 |
Group 2024 |
|---|---|---|---|
| EQUITY AND LIABILITIES | |||
| Equity | |||
| Share capital | 122,463 | 111,463 | 111,463 |
| Reserve for exchange rate adjustment | -49,622 | -38,726 | -48,864 |
| Reserve for cash flow hedge | 0 | 0 | 0 |
| Transferred result | 842,719 | 747,808 | 756,496 |
| Proposed dividend | 0 | 0 | 0 |
| Total equity ex. minority interests | 915,560 | 820,545 | 819,095 |
| Minority interests | 93 | 487 | 60 |
| Total equity | 915,653 | 821,032 | 819,155 |
| Liabilities | |||
| Non-current liabilities | |||
| Deferred tax | 43,891 | 40,349 | 40,912 |
| Credit institutions | 507,971 | 522,541 | 514,625 |
| Convertible bonds | 0 | 88,881 | 88,927 |
| Other debts | 691 | 5,714 | 4,106 |
| Accruals and deferred income | 70,529 | 68,057 | 70,245 |
| Total non-current liabilities | 623,082 | 725,542 | 718,815 |
| Current liabilities | |||
| Credit institutions | 113,779 | 103,353 | 85,144 |
| Convertible bonds | 0 | 0 | 0 |
| Trade payables and other payables | 74,226 | 77,872 | 55,304 |
| Corporation tax | 0 | 356 | 946 |
| Accruals and deferred income | 5,294 | 5,754 | 5,534 |
| Total current liabilities | 193,299 | 187,335 | 146,928 |
| Total liabilities | 816,381 | 912,877 | 865,743 |
| TOTAL EQUITY AND LIABILITIES | 1.732,034 | 1.733,909 | 1.684,898 |
{12}------------------------------------------------
EQUITY STATEMENT
| EQUITY STATEMENT (condensed) tDKK |
Group H1 2025 |
Group H1 2024 |
|---|---|---|
| Equity 1 January | 819,095 | 722,196 |
| Result of the period | 4,756 | 0 |
| Other total income | -725 | -4.734 |
| Conversion of bonds | 92,226 | 0 |
| Capital increase | 0 | 96,923 |
| Utilisaton of warrants | 550 | 0 |
| Warrants | 0 | 573 |
| Purchase of own shares | 0 | -8,447 |
| Dividend | 0 | 0 |
| Total income for the period | 96,464 | 84,315 |
| Equity 30 June | 915,559 | 806,511 |
At the annual general meeting on 16 April 2024 and 29 April 2025, FirstFarms was authorised to acquire 10 % of the company's own shares. In first half year 2025, the company utilised this authorisation and acquired 4,711 own shares. The stock of own shares is hereafter 14,661 pcs.
{13}------------------------------------------------
CASH FLOW STATEMENT
| CASH FLOW STATEMENT tDKK |
Group H1 2025 |
Group H1 2024 |
|---|---|---|
| Pre-tax result (Int the parent company ex. result of subsidiaries) | 6,515 | 18,016 |
| Adjustments for non -monetary operating items etc.: | ||
| Depreciation/amortisation | 32,293 | 29,703 |
| Reversal of profit, sale of non -current assets and badwill | 0 | -1.005 |
| Value adjustment of biological assets | -7,161 | -8,445 |
| Financial income | -2,602 | -5.286 |
| Financial costs | 18,178 | 22,581 |
| Sharebased remuneration | 550 | 573 |
| Cash flow generated from operations before change in working capital | 47,773 | 56,137 |
| Change in working capital | -34,880 | -14,165 |
| Cash flow from main activities | 12,893 | 41,972 |
| Interest received | 2,602 | 5.286 |
| Interest paid | -18,178 | -22,581 |
| Paid corporation tax | 4,311 | -7,174 |
| Cash flow from operating activities | 1,628 | 17,503 |
| Purchase of shares in Agri Invest | 0 | 0 |
| Sale of tangible assets, paid | 242 | 5,097 |
| Acquisition of tangible assets | -86,396 | -60,272 |
| Cash flow from investing activities | -86,154 | -55,175 |
| Paid dividend | 0 | 0 |
| Buy-back of own shares | -343 | -8,447 |
| Capital increase | 0 | 96,923 |
| Proceeds from taking up convertible bonds | 0 | 88,881 |
| Repayment of other debts | 0 | -7,336 |
| Proceeds from loans | 25,656 | 39,596 |
| Loan repayment | -6,758 | -16,651 |
| Cash flow from financing activities | 18,555 | 192,966 |
| Cash flow of the period | -65,971 | 155,294 |
| Available, at the beginning | 137,703 | 25,880 |
| Exchange rate adjustment of available | 0 | 0 |
| Available, at closing | 71,732 | 181,174 |

{14}------------------------------------------------
| SEGMENT INFORMATION H1 2025 tDKK |
Romanian activities |
Slovakian activities |
Hungarian activities |
Czech activities |
Danish activities |
Intercompany elimation |
Total |
|---|---|---|---|---|---|---|---|
| Total turnover | 23,008 | 86,807 | 48,364 | 44,663 | 5,997 | -16,678 | 192,161 |
| Production subsidies | 5,744 | 18,051 | 3,074 | 1,148 | 0 | 0 | 28,017 |
| Value adjustment of biological assets | 11,200 | -11,372 | 4,898 | 2,435 | 0 | 0 | 7,161 |
| Earnings before depreciations (EBITDA) | 23,206 | 25,608 | 13,751 | 3,958 | -12,139 | 0,000 | 54,384 |
| Depreciations | -7,802 | -15,925 | -6,691 | -1,850 | -25 | 0 | -32,293 |
| Earnings from primary operation (EBIT) | 15,404 | 9,683 | 7,060 | 2,108 | -12,164 | 0,000 | 22,091 |
| Financial income | 1557 | 13 | 16 | 1345 | 11,669 | -11,998 | 2,602 |
| Financial costs | -8578 | -6,733 | -8,675 | -980 | -5,210 | 11,998 | -18,178 |
| Result before tax | 8383 | 2,963 | -1599 | 2,473 | -5,705 | 0 | 6,515 |
| Assets | 415,589 | 706,324 | 330,001 | 203,277 | 607,369 | -530,526 | 1.732,034 |
| Plant investments *) | 54,525 | 25,279 | 6,592 | 0,000 | 0 | 0 | 86,396 |
| Liabilities | 337,202 | 425,234 | 343,721 | 65,344 | 178,675 | -533,795 | 816,381 |
| SEGMENT INFORMATION H1 2024 tDKK |
Romanian activities |
Slovakian activities |
Hungarian activities |
Czech activities |
Danish activities |
Intercompany elimation |
Total |
|---|---|---|---|---|---|---|---|
| Total turnover | 2,685 | 121,331 | 58,138 | 52,101 | 5,719 | -20,276 | 219,698 |
| Production subsidies | 10,088 | 23,149 | 2,734 | 1,643 | 0 | 0 | 37,614 |
| Value adjustment of biological assets | 2,500 | 3,671 | 4,062 | -1.788 | 0 | 0 | 8,445 |
| Earnings before depreciations (EBITDA) | 6,688 | 34,361 | 21,274 | 6,766 | -4,075 | 0 | 65,014 |
| Depreciations | -6,096 | -15,186 | -6,681 | -1,715 | -25 | 0 | -29,703 |
| Earnings from primary operation (EBIT) | 0,592 | 19,175 | 14,593 | 5,051 | -4,100 | 0 | 35,311 |
| Financial income | 465 | 223 | 25 | 168 | 16,995 | -12,6 | 5,286 |
| Financial costs | -7.060 | -9,474 | -10.925 | -1,094 | -6,618 | 12,590 | -22,581 |
| Result before tax | -6,003 | 9,924 | 3,693 | 4,125 | 6,277 | 0 | 18,016 |
| Assets | 325,898 | 702,351 | 336,349 | 202,182 | 585,746 | -418,617 | 1.733,909 |
| Plant investments *) | 22.451 | 24,555 | 9,364 | 3,902 | 0 | 0 | 60,272 |
| Liabilities | 251,009 | 405,370 | 327,904 | 67,375 | 277,020 | -415,801 | 912,877 |
*) Investments include investments in machinery, land and buildings.
FirstFarms' report compulsory segments are constituted by the business units in Slovakia, Romania, Hungary and the Czech Republic.In Slovakia, we operate within pig, milk and crop production. In Romania, we operate within crop production. In Hungary and in the Czech Republic within pig and crop production. The four business units are operated independently, as each unit has different management, activities and customers. The report compulsory segments are identified without aggregation of operation segments.
{15}------------------------------------------------
Products
FirstFarms' turnover primarily concerns milk, pigs and crops.
The turnover is specified:
| tDKK | Romania H1 2025 |
Romania H1 2024 |
Slovakia H1 2025 |
Slovakia H1 2024 |
Hungary H1 2025 |
Hungary H1 2024 |
Czech H1 2025 |
Czech H1 2024 |
|
|---|---|---|---|---|---|---|---|---|---|
| Milk | 0 | 0 | 30,039 | 58,680 | 0 | 0 | 0 | 0 | |
| Cows and calves | 0 | 0 | 3,666 | 4,860 | 0 | 0 | 0 | 0 | |
| Piglets and slaughter pigs | 0 | 0 | 29,138 | 35,439 | 48,078 | 57,326 | 44,618 | 51,641 | |
| Crops | 22,861 | 2,369 | 22,393 | 21,100 | 0 | 198 | 0 | 0 | |
| Other | 147 | 316 | 1,571 | 1,252 | 286 | 614 | 45 | 460 | |
| Total | 23,008 | 2,685 | 86,807 | 121,331 | 48,364 | 58,138 | 44,663 | 52,101 |
Geographical information
FirstFarms operates in Romania, Slovakia, Hungary and the Czech Republic. Management and strategic services are provided by the parent company to the subsidiaries.
The subsidiaries are partly financed by loans from the parent company. When presenting information on geographical areas, information on the distribution of turnover by geographic segment is calculated based on the geographical location.Distribution of assets by geographic segment is based on the physical location of the assets.
| TURNOVER tDKK |
Group H1 2025 |
Group H1 2024 |
|---|---|---|
| Milk | 30,039 | 58,680 |
| Cows and calves | 3,666 | 4,860 |
| Piglets and slaughter pigs | 111,612 | 131,704 |
| Crops | 45,254 | 21,817 |
| Other | 1,590 | 2,637 |
| Total | 192,161 | 219,698 |
{16}------------------------------------------------
INVESTOR INFORMATION
Basic data
Stock exchange: Nasdaq Copenhagen A/S
Index: SmallCap
Sector: Konsumentvarer ISIN code: DK0060056166
Short name: FFARMS
Contact us: FirstFarms A/S Majsmarken 1 7190 Billund
Group CFO Michael Hyldgaard [email protected] +45 75 86 87 87
Financial calendar
13 March 2025 Annual report 2024 29 April 2025 Annual general meeting
28 May 2025 Interim financial report 1 January – 31 March 2025 27 August 2025 Interim financial report 1 January – 30 June 2025
26 November 2025 Interim financial report 1 January – 30 September 2025
Find more information about FirstFarms here: www.firstfarms.com
{17}------------------------------------------------

VISION
We want to be one of Europe's best operated and most profitable companies in the area of agriculture and food products.
PURPOSE
Contribute to a healthier world with food products, which are produced with respect for people, animals, soil and climate.
MISSION
We operate FirstFarms with responsibility for the surrounding communities, and we deliver highest quality which is primarily sold locally.
We act on new opportunities, that create value for our investors and for the surroundings.
Every day, we work on creating a more sustainable company.
{18}------------------------------------------------
